AABB News spotlights three pioneering leaders in the blood and biotherapies community who are at the forefront of sickle cell disease research and advancing the treatment of the disease worldwide.
16 min read |Members Only |FeatureIn this issue, AABB News highlights global advancements in sickle cell disease treatment.
2 min read |Open Access |President’s MessageExperts discuss the role of transfusion in managing sickle cell disease and explore how emerging novel therapies may result in transfusion independence.
9 min read |Members Only |FeatureIn honor of World Sickle Cell Awareness Day, AABB News features warrior Jimi Olaghere, a gene therapy recipient and advocate for patients with sickle cell disease.
8 min read |Open Access |FeatureTom Whitehead discusses his plans for his keynote address – and why his family’s story is particularly germane for the AABB Annual Meeting’s General Session.
3 min read |Open Access |Annual MeetingThis month’s “In Conversation” interview features filmmaker Janks Morton and his latest project, SICKLE, an emotional and inspiring docuseries that shines a spotlight on sickle cell warriors.
8 min read |Open Access |In ConversationThe AABB Foundation will host a variety of events in conjunction with the AABB Annual Meeting to promote scientific research, innovation, collaboration and networking for the blood and biotherapies community.
5 min read |Open Access |AABB Foundation: Shaping the IndustryCatherine Karekezi, PhD, discusses empowering communities to prevent and manage non-communicable diseases.
5 min read |Open Access |White CoatsThe new guidelines offer recommendations for transfusion based on specific patient criteria, and guidelines vary depending on patients’ needs.
3 min read |Members Only |High PriorityOf Note: News stories from the field.
5 min read |Members Only |Of NoteAABB News checked in with several members who regularly attend the AABB Annual Meeting to learn why they consider this a must-attend event for the blood and biotherapies field.
6 min read |Open Access |Annual MeetingFrom reducing stress to enhancing self-awareness, the emotional benefits of journaling are numerous and well-documented.
4 min read |Members Only |Be WellTayler Reeves, MS, MLS(ASCP), discusses her passion for giving back and mentorship.
2 min read |Members Only |Membership FocusTransfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion JournalKeep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement
Officer Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.